Cariporide mesilate

N/A

Report date: 2022/05/16 18:00:47
NME

Base Information

Drug NameCariporide mesilate
Drug Alias Name卡立泊来德HOE 604HOE 642HOE-604HOE-642
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/hydrogen exchanger 1 inhibitors
TargetsSodium/hydrogen exchanger 1
Therapy Area/IndicationsMyocardial InfarctionAngina, UnstableMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsMyocardial InfarctionAngina, UnstableMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A